Related Experiment Video
Updated: Jun 22, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Signaling-dependent nuclear export of estradiol receptor controls cell cycle progression in breast cancer cells
Gabriella Castoria1, Antimo Migliaccio, Ferdinando Auricchio
1Department of General Pathology, II University of Naples, Napoli, Italy. gabriella.castoria@unina2.it
Abstract:
Estradiol receptor plays a key role in breast cancer and specific hormonal therapies blocking the receptor functions have been developed. Unfortunately, many patients become resistant to this treatment and develop metastatic breast tumors. The causes of breast tumor progression and hormonal therapy resistance are still debated. Many proteins are mislocalized in human cancers, and increasing evidence indicates that nuclear exclusion of estradiol receptor is involved in tumorigenesis of breast cancer cells and hormonal therapy resistance. Therefore, analysis of intracellular localization of estradiol receptor together with screening for specific compounds that redirect the mislocalized receptor to the correct subcellular compartment is a very promising approach to the discovery of novel anticancer compounds. We recently dissected estradiol receptor nuclear export in breast cancer cells and its dependence on PI3-K. This export has a strong impact on cell cycle progression. A peptide mimicking the nuclear export sequence of estradiol receptor specifically traps the receptor in nuclear compartment and blocks the S-phase entry of target cells.
Insights
Estradiol receptor nuclear export drives breast cancer progression and resistance to hormonal therapies. A novel peptide that mimics the estradiol receptor nuclear export sequence traps the receptor in the nucleus, blocking cancer cell growth.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Estradiol receptor is crucial in breast cancer, with therapies targeting its function.
- Hormonal therapy resistance and metastasis remain significant challenges in breast cancer treatment.
- Mislocalization of proteins, including estradiol receptor nuclear exclusion, is implicated in cancer development and therapy resistance.
Purpose of the Study:
- To investigate the role of estradiol receptor intracellular localization in breast cancer progression and hormonal therapy resistance.
- To identify compounds that can correct estradiol receptor mislocalization for novel anticancer drug discovery.
- To analyze estradiol receptor nuclear export pathways and their impact on cell cycle progression.
Main Methods:
- Dissection of estradiol receptor nuclear export in breast cancer cells.
- Investigation of the dependence of nuclear export on PI3-K signaling.
- Development and testing of a peptide mimicking the estradiol receptor nuclear export sequence.
Main Results:
- Estradiol receptor nuclear exclusion is linked to breast cancer tumorigenesis and therapy resistance.
- Estradiol receptor nuclear export significantly impacts cell cycle progression.
- A specific peptide successfully trapped estradiol receptor in the nucleus and inhibited cancer cell proliferation.
Conclusions:
- Targeting estradiol receptor intracellular localization offers a promising strategy for overcoming hormonal therapy resistance.
- Modulating estradiol receptor nuclear export with specific peptides can be a viable approach for developing new breast cancer treatments.
- Understanding the mechanisms of estradiol receptor mislocalization is key to improving breast cancer patient outcomes.
Related Concept Videos
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Mitogens and the Cell Cycle
Signal Transduction: Overview
Typically, signal transduction involves three...
Regulation of Nuclear Protein Sorting
Negative Regulator Molecules
Chemical Signaling in the Endocrine System
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...

